Why Patients Are Being Forced to Switch to a 2nd-Choice Obesity Drug

By Rebecca Robbins and Reed Abelson from NYT Health https://ift.tt/6Ha89sB
via IFTTT
Health
GLP-1 RAs (Drug), Drugs (Pharmaceuticals), Prices (Fares, Fees and Rates), Health Insurance and Managed Care, Weight, Obesity, Research, Clinical Trials
New York Times
May 12, 2025 at 03:31AM